Intranasal vaccine trial a success, submitted data: Bharat Biotech

Joint MD Suchitra K Ella said if approved, the intranasal vaccine would be easier to deploy in mass immunisation campaigns as it has an easy-to-administer formulation and delivery device. “Vectored vaccines also enable faster development of targeted vaccines in response to emerging variants of concern,” she said.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.